1. Home
  2. PSTG vs RPRX Comparison

PSTG vs RPRX Comparison

Compare PSTG & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pure Storage Inc.

PSTG

Pure Storage Inc.

HOLD

Current Price

$67.30

Market Cap

23.0B

Sector

Technology

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$49.87

Market Cap

19.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSTG
RPRX
Founded
2009
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.0B
19.5B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
PSTG
RPRX
Price
$67.30
$49.87
Analyst Decision
Buy
Strong Buy
Analyst Count
19
4
Target Price
$90.05
$50.00
AVG Volume (30 Days)
2.1M
2.6M
Earning Date
05-27-2026
05-06-2026
Dividend Yield
N/A
1.88%
EPS Growth
77.42
N/A
EPS
0.55
1.78
Revenue
$3,662,843,000.00
$2,378,193,000.00
Revenue This Year
$21.76
$38.30
Revenue Next Year
$15.70
$4.80
P/E Ratio
$123.45
$28.08
Revenue Growth
15.61
5.06
52 Week Low
$43.51
$31.58
52 Week High
$100.59
$49.99

Technical Indicators

Market Signals
Indicator
PSTG
RPRX
Relative Strength Index (RSI) 60.46 67.49
Support Level $64.57 $35.32
Resistance Level $76.63 N/A
Average True Range (ATR) 2.80 0.92
MACD 0.86 0.14
Stochastic Oscillator 100.00 94.35

Price Performance

Historical Comparison
PSTG
RPRX

About PSTG Pure Storage Inc.

Pure Storage Inc is a U.S.-based company that provides an enterprise data storage platform that transforms business through a dramatic increase in performance and reduction in complexity and costs. It generates revenue from two sources: product revenue, which includes the sale of integrated storage hardware and embedded operating system software; and subscription services revenue, which includes Evergreen Storage subscriptions, a unified subscription that includes Pure as-a-Service, Cloud Block Store, and Portworx. Subscription services revenue also includes professional services offerings such as installation and implementation consulting services.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: